SCHEMBL4124789

SCHEMBL4124789

O=P(O)(O)CS

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL693381 0.75
SCHEMBL644998 0.73
SCHEMBL2161910 0.72
Phosphoric Acid SCHEMBL5829113 0.70
Phosphoric Acid SCHEMBL29243188 0.70 CA2 (0.43)
Medronic Acid SCHEMBL8350837 0.67 KDM4E (1.00)
SCHEMBL699017 0.67
Medronic Acid SCHEMBL66716 0.67
SCHEMBL215192 0.67
SCHEMBL8352725 0.67 TYMS (0.69)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 226 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4352015-A1 PROCESS AND PRODUCTS FOR REMOVAL OF CONTAMINANTS IN LIQUID COMPOSITIONS Numat Technologies Inc. (US) 2024-04-17 EP claimed
CN-117642364-A Method and product for removing contaminants from liquid compositions 纽麦特科技公司 2024-03-01 CN claimed
US-20230038608-A1 PROCESS AND PRODUCTS FOR REMOVAL OF CONTAMINANTS IN LIQUID COMPOSITIONS NUMAT TECHNOLOGIES, INC. (US) 2023-02-09 US claimed
WO-2023003823-A1 PROCESS AND PRODUCTS FOR REMOVAL OF CONTAMINANTS IN LIQUID COMPOSITIONS NUMAT TECHNOLOGIES, INC. (US) 2023-01-26 WO claimed
CN-118355120-A Compositions and methods for modulating APOC3 expression 迪克纳制药公司 2024-07-16 CN disclosed
US-12037358-B2 Compositions comprising reversibly modified oligonucleotides and uses thereof DICERNA PHARMACEUTICALS, INC. (US) 2024-07-16 US disclosed
US-12037586-B2 4′-phosphate analogs and oligonucleotides comprising the same DICERNA PHARMACEUTICALS, INC. (US) 2024-07-16 US disclosed
EP-4392556-A1 COMPOSITIONS AND METHODS FOR INHIBITING ?LPHA-1 ANTITRYPSIN EXPRESSION Dicerna Pharmaceuticals, Inc. (US) 2024-07-03 EP disclosed
CN-118284695-A Pharmaceutical combination for treating HBV 豪夫迈·罗氏有限公司 2024-07-02 CN disclosed
US-20240182901-A1 METHODS AND COMPOSITIONS FOR INHIBITING EXPRESSION OF LDHA DICERNA PHARMACEUTICALS, INC. 2024-06-06 US disclosed
EP-4352015-A1 PROCESS AND PRODUCTS FOR REMOVAL OF CONTAMINANTS IN LIQUID COMPOSITIONS Numat Technologies Inc. (US) 2024-04-17 EP disclosed
US-20240117351-A1 COMPOSITIONS AND METHODS FOR INHIBITING GENE EXPRESSION IN THE CENTRAL NERVOUS SYSTEM NOVO NORDISK A/S (DK) 2024-04-11 US disclosed
US-4436899-A REACTION OF ORGANIC PHOSPHONATE OR PHOSPHATE WITH TETRAVALENT METAL COMPOUND OCCIDENTAL RESEARCH CORPORATION (US) 1984-03-13 US disclosed
EP-0099949-A1 Improved aqueous processable, positive-working photopolymer compositions E.I. DU PONT DE NEMOURS AND COMPANY (US) 1984-02-08 EP disclosed
US-4415652-A ALKENYLAMINE-MODIFIED MALEIC ANHYDRIDE COPOLYMER, A MERCAPTO-CONTAINING CARBOXYLIC ACID AND PHOTOINITIATOR; LITHOGRAPHY E. I. DU PONT DE NEMOURS & CO. (US) 1983-11-15 US disclosed
US-4415651-A UNSATURATED ADDITION POLYMER, A MERCAPTO-CONTAINING CARBOXYLIC ACID AND A PHOTOINITIATORS; LITHOGRAPHY E. I. DU PONT DE NEMOURS AND COMPANY (US) 1983-11-15 US disclosed
US-4276410-A FOR USE AS ION COMPLEXERS OCCIDENTAL RESEARCH CORPORATION (US) 1981-06-30 US disclosed
US-4256872-A INTERCALATION COMPOUNDS PREPARED BY THE METATHESIS REACTION IN LIQUID PHASE OF AN INORGANIC TETRAVALENT METAL COMPOUND AND AN ORGANIC PHOSPHONATE; ION EXCHANGERS OCCIDENTAL RESEARCH CORPORATION (US) 1981-03-17 US disclosed
US-4232146-A Process for preparing layered organophosphorus inorganic polymers OCCIDENTAL RESEARCH CORPORATION (US) 1980-11-04 US disclosed
US-3779723-A THIXOTROPIC COMPOSITIONS SHELL OIL CO 1973-12-18 US disclosed